A Study to Collect Survival Data on Patients Previously Enrolled in Abraxane Pancreatic Cancer Study CA046.

• Status: Completed
• Trial end date: 2015-04-16
• Target enrollment: 0
• Participant gender: All

Summary

A study to collect survival data on patients previously enrolled in Abraxane pancreatic cancer study CA046.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Celgene; Celgene Corporation
• Treatments: Albumin-Bound Paclitaxel

Criteria

Inclusion Criteria:

• Must have been enrolled in the CA046 study Must have been living at the time of the last survival follow-up (approximate timeframe - end of March, 2013) Must understand and be able to give informed consent (if a subject is deceased, proper legal consent (ie, next of kin, legal representative) will be obtained prior to collection of data)

Exclusion Criteria:

• Consent refused for any reason